Pharmafile Logo

Event Logistics

National Institute for Health and Care Excellence NICE logo

UK market access issues put on hold during election

NICE appraisals and Cancer Drugs Fund appeals will not be undertaken until May

- PMLiVE

Gilead under fire for Sovaldi anti-diversion policy

Accused as generic versions of the drug start to reach the market

EISAI

Eisai to make 200 cuts to US operations

Japanese firm says the restructure will help it stay competitive

- PMLiVE

AZ’s Onglyza may increase mortality, says FDA

Kombiglyze also under scrutiny

- PMLiVE

RSA name Kris Richards as senior consultant

Will aid the executive interims team

- PMLiVE

Pfizer launch grants programme for cardiovascular research

PCSK9 initiative is an extension of existing ASPIREprogramme

- PMLiVE

Pfizer and Merck flesh out Xalkori alliance details

First stage of building a combined oncology sales organisation

Shire Basingstoke

Silver lining as Shire rare disease programme hits a setback

Alagille syndrome candidate fails to meet phase II targets

- PMLiVE

IQWiG passes Boehringer lung cancer drug

Germany’s cost assessor says it can extend life in some patients, but benefit it ‘minor'

- PMLiVE

Pfizer and Pharmacy Voice launch NHS campaign

Campaign aims to reduce inappropriate use of A&E services 

- PMLiVE

Piramal sells clinical research arm to Indoco

Piramal Clinical Research sold for an undisclosed sum

- PMLiVE

Going the distance

Sanofi’s Pascale Witz on driving through change

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links